At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BJDX Bluejay Diagnostics Inc
Trading 11-05 09:32:51 EST
0.0801
+0.0072
+9.88%
High0.0801
Low0.0741
Vol336.32K
Open0.0741
D1 Closing0.0729
Amplitude8.23%
Mkt Cap1.33M
Tradable Cap1.32M
Total Shares16.55M
T/O25.38K
T/O Rate2.04%
Tradable Shares16.49M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Bluejay Diagnostics Closes $8.8 Million Public Offering
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.